The operational impact of Covid-19
NSF PH White Paper - Steamlining Pharma Operations in the Wake of COVID-19
Managing a quality system with a 50% staff reduction
Imagine you are the quality director of a site manufacturing critical medicinal products or medical devices. You have a sickness absence rate of 50% of QA and QC staff.
Live system assessments: Why do them?
I have a vivid memory of a certain “pre-exam stress” period as my old production site prepared for my first regulatory inspection in the early 1990s. The theory, even then, was that...
Words of wisdom from Anders Vinther
Martin Lush talks with a veteran pharma professional to get their point of view on the industry and beyond.
Documentation complexity at crisis point
Do we focus too much on the paperwork, to the detriment of product and patients? Has documentation become so complex it’s become a dangerous distraction and your biggest risk?
The vital importance of winning the talent war and investing education
by Martin Lush
How to Get More Training Budget in a World of Scarcity
If you think training is expensive, try ignorance. In this white paper Martin Lush highlights the effectiveness of training programs when they are linked to a specific business need,...
Is Your Outsourcing Project 'Out of Mind and Out of Hand"
John Johnson discusses the risks associated with global supply chains and suggests a defined outsourcing management process to tackle them. He highlights the priorities, costs and...
